ClinicalTrials.gg
RecruitingNCT04894864Updated Jun 16, 2026

Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair

A Phase 4 interventional study of Opioid-Based Anesthesia-Analgesia Strategy and Opioid-free Anesthesia-Analgesia Strategy in Elective Surgical Procedures, Postoperative Pain and Anesthesia, sponsored by University of Crete. Recruiting at 1 site in Greece. Open to participants aged 40 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-06-16.

Sponsored by University of Crete · Phase 4, Interventional, and Basic science

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Oct 2020, registered Apr 2021).
  • Started Oct 2020; still recruiting 6 years 1 month later.
Phase
Phase 4
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
40 Years to 85 Years
Sex
All
01

Study summary

Open Abdominal Aortic Aneurysm (AAA) repair is a high-risk surgical procedure accompanied by intense endocrine and metabolic responses to surgical stress, with subsequent activation of the inflammatory cascade, cytokine and acute-phase protein release, and bone marrow activation. There is a proven correlation of surgical stress, which patients undergoing open AAA repair are subjected to, with patient outcome, morbidity/mortality, intensive care unit stay and overall length of stay. Modern general anesthetic techniques have been revised and rely on perioperative multimodal anesthetic and analgesic strategies for improved overall patient outcome. Based on this context of a multimodal anesthetic technique and having taken into consideration the international "opioid-crisis" epidemic, an Opioid Free Anesthesia-Analgesia (OFA-A) strategy started to emerge. It is based on the administration of a variety of anesthetic/analgesic agents with different mechanisms of action, including immunomodulating and anti-inflammatory effects.

Our basic hypothesis is that the implementation of a perioperative multimodal OFA-A strategy, involving the administration of pregabalin, ketamine, dexmedetomidine, lidocaine, dexamethasone, dexketoprofen, paracetamol and magnesium sulphate, will lead to attenuation of surgical stress response compared to a conventional Opioid-Based Anesthesia-Analgesia (OBA-A) strategy. Furthermore, the anticipated attenuation of the inflammatory response, is pressumed to be associated with equal or improved analgesia, compared to a perioperative OBA-A technique.

Read the detailed description

Open abdominal aortic aneurysm (AAA) repair surgery is a high-risk operation, often performed on high-risk patients. Despite advancements made in diagnosis, management, surgical techniques and treatment of these patients, morbidity and mortality remain high. Mortality after open AAA repair remains higher than the average mortality of the matched population for age and sex. Debate is ongoing as to whether open AAA repair or endovascular aneurysm repair (EVAR) is better in terms of overall long-term survival rate.

Regarding open AAA repair, the very nature of the surgery itself, with surgical trauma, aortic cross clamping and its resulting ischemia-reperfusion injury, and cellular interactions of blood with the biomaterial surface of the graft, causes intense and varied metabolic, endocrine and immunological responses. These surgical stress-related responses are evident as marked increases in inflammatory cytokines such as TNF-a, IL-1a, IL-6, IL-8, IL-10, stimulation of the sympathetic system, and stimulation of the hypothalamic-pituitary-adrenal axis, caused by release of CRH and AVP. High levels of IL-6, peaking at 4-48h after clamp removal, have been associated with serious postoperative complications and its levels reflect the intensity of surgical trauma following AAA repair. Other inflammation markers such as CRP and leukocytes have also been shown to increase postoperatively.

While the surgical technique has been extensively studied as to the role it plays on the control of the surgical stress response, patient outcome, morbidity and overall mortality, fewer studies have been conducted to study the effect of the anesthetic management on these factors. While most of them have been focusing on the comparison of general anesthetic vs regional techniques, only few compare different general anesthetic techniques on patient outcome.

Modern general anesthetic techniques have been revised and rely on a multimodal anesthetic and analgesic perioperative regimen for improved patient outcome. A multimodal regimen requires the administration of at least 2 factors with different mechanisms of action. At least one factor causes inhibition of central sensitization and at least another one inhibits the peripheral sensitization of the nervous system, as a response to painful surgical stimuli, mitigating adverse neuroplasticity. One such example, is an Opioid-Free Anesthetic-Analgesic (OFA-A) strategy, which implements a variety of pharmacological agents, including some with demonstrated immunomodulating and anti-inflammatory effects. Apart from sparing any opioid-related adverse effects, an OFA-A multimodal strategy targets optimal analgesia with a multitude of factors in the lowest possible dose, aiming for additive or synergistic effects. An additional advantage of using an OFA-A technique is the prevention of opioid-induced hyperalgesia.

Our hypothesis is that implementation of a multimodal OFA-A strategy, leads to a decreased sympathetic and inflammatory response, compared to conventional opioid-based anesthetic techniques. A decreased inflammatory and stress response as expressed by reduced levels of IL-6, IL-8, IL-10, TNF-a, CRP, cortisol, arginine vasopressin (AVP), white blood cells count and hemodynamic stability is expected to decrease peripheral and central sensitization, contributing to better postoperative analgesia.

02

Conditions studied

  • Elective Surgical Procedures
  • Postoperative Pain
  • Anesthesia
  • Opioid Use
  • Abdominal Aortic Aneurysm Without Rupture
  • Vascular Surgical Procedure
  • Interleukin 6
  • Immunomodulators

Browse trials for

Keywords

  • Opioid-free Anesthesia-Analgesia
  • Cytokines
  • Opioid-based Anesthesia-Analgesia
  • Haemodynamic Stability
  • Open Abdominal Aortic Aneurysm Repair
  • Immunomodulation
  • Inflammatory Markers
03

In context

Pain, Postoperative

5,640 studies on the registry are indexed under Pain, Postoperative; 1,230 are open to participants now.

This study's planned enrollment of 40 is below the median of 75 across 4,821 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

University of Crete is the lead sponsor of 23 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patient Consent
  2. Age between 40 and 85 years old
  3. Patients undergoing Elective Open Abdominal Aortic Infrarenal Aneurysm Repair

Exclusion criteria

Exclusion Criteria:

  1. patients
  2. Patients with active infection
  3. Reoperation on the aorta
  4. Inflammatory bowel Disease
  5. Chronic Inflammatory conditions (e.g. Rheymatoid arthritis, Psoriatic arthritis)
  6. Chronic or immunosuppressive drug use
  7. Intraoperative transfusion with >2 units of packed Red Blood Cells
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Phase 4
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Opioid-Based Anesthesia Analgesia

    Premedication: IM Midazolam 0.05-0.07mg/kg. Anesthesia induction: Midazolam 0.03mg/kg, Propofol 2-3mg/kg, Fentanyl 1-2mcg/kg and Cisatracurium 0.2mg/kg or alternatively Rocuronium 0.6-1.2mg/kg. Anesthesia maintenance: Desflurane set at approximately 1 MAC, Morphine 0.1-0.12mg/kg, Fentanyl 1-2mcg/kg during induction and 50-100mcg prn, Paracetamol 1g +/- Dexketoprofen trometamol 50mg, along with Ondansetron 4mg or Droperidol 0.625mg. Wound infiltration: Ropivacaine 75-150mg. ICU stay sedation: Remifentanil infusion, until removal of the endotracheal tube. Surgical ward: PCA pump with Morphine for the first 3 postoperative days. Additional postoperative analgesia: Paracetamol 1g x3 +/- Dexketoprofen trometamol 50mg x2. Rescue therapy only: Tramadol 50-100mg.

    Drug: Opioid-Based Anesthesia-Analgesia Strategy

  • Active comparator
    Opioid-Free Anesthesia Analgesia

    Premedication: Pregabalin 50-150mg x2, IM Midazolam 0.05-0.07mg/kg. Anesthesia induction: Midazolam 0.03mg/kg, Dexdmedetomidine 0.5-1mcg/kg, Lidocaine 1mg/kg, Propofol 2-3mg/kg, Ketamine 1-1.5mg/kg, Hyoscine 10mg, Cisatracurium 0.2mg/kg or alternatively Rocuronium 0.6-1.2mg/kg, Magnesium sulphate 2.5-5g and Dexamethasone 8-16mg. Anesthesia maintenance: Desflurane set at \~1 MAC, Dexmedetomidine 0.2-1.2mcg/kg/h, Lidocaine 0.5-1mg/kg/h, Ketamine 0.3-0.5mg/kg prn, Paracetamol 1g +/- Dexketoprofen trometamol 50mg, and Ondansetron 4mg or Droperidol 0.625mg. Wound infiltration: Ropivacaine 75-150mg. ICU sedation: Dexmedetomidine + Lidocaine infusions, until removal of the ETT. Surgical ward: PCA pump with Ketamine, Lidocaine, Clonidine and Midazolam for the first 3 postoperative days. Additionally, Pregabalin 50mg per os x1 and 25mg x1, up to x2, Paracetamol 1g x3 +/- Dexketoprofen trometamol 50mg x2. Rescue therapy only: Tramadol 50-100mg.

    Drug: Opioid-free Anesthesia-Analgesia Strategy

Interventions

  • DrugOpioid-Based Anesthesia-Analgesia Strategy

    A perioperative Opioid-Based multimodal Anesthesia-Analgesia strategy will be implemented as described in the Opioid-Based arm of the study.

    Also known as: Opioid-Based Anesthesia, OBA-A

  • DrugOpioid-free Anesthesia-Analgesia Strategy

    A perioperative Opioid-Free multimodal Anesthesia-Analgesia strategy will be implemented as described in the Opioid-Free arm of the study.

    Also known as: Opioid-Free Anesthesia, OFA-A

06

What researchers measure

Primary outcomes

  1. Surgical Stress Response - IL-6 - Preoperatively

    Inflammatory response and stress response as quantified by IL-6 serum levels. Blood sample collection will take place in both study groups.

    Time frame: 1) Preoperatively (as a baseline)

  2. Surgical Stress Response - IL-6 - 15 minutes after aortic cross-clamp

    Inflammatory response and stress response as quantified by IL-6 serum levels. Blood sample collection will take place in both study groups.

    Time frame: 2) 15 minutes after aortic cross-clamping

  3. Surgical Stress Response - IL-6 - 60 minutes after aortic cross-clamp

    Inflammatory response and stress response as quantified by IL-6 serum levels. Blood sample collection will take place in both study groups.

    Time frame: 3) 60 minutes after aortic cross-clamp release

  4. Surgical Stress Response - IL-6 - 24 hours after aortic cross-clamp release

    Inflammatory response and stress response as quantified by IL-6 serum levels. Blood sample collection will take place in both study groups.

    Time frame: 4) 24 hours after aortic cross-clamp release

  5. Surgical Stress Response - IL-8 - Preoperatively

    Inflammatory response and stress response as quantified by IL-8 serum levels. Blood sample collection will take place in both study groups.

    Time frame: 1) Preoperatively (as a baseline)

  6. Surgical Stress Response - IL-8 - 15 minutes after aortic cross-clamp

    Inflammatory response and stress response as quantified by IL-8 serum levels. Blood sample collection will take place in both study groups.

    Time frame: 2) 15 minutes after aortic cross-clamping

  7. Surgical Stress Response - IL-8 - 60 minutes after aortic cross-clamp

    Inflammatory response and stress response as quantified by IL-8 serum levels. Blood sample collection will take place in both study groups.

    Time frame: 3) 60 minutes after aortic cross-clamp release

  8. Surgical Stress Response - IL-8 - 24 hours after aortic cross-clamp release

    Inflammatory response and stress response as quantified by IL-8 serum levels. Blood sample collection will take place in both study groups.

    Time frame: 4) 24 hours after aortic cross-clamp release

  9. Surgical Stress Response - IL-10 - Preoperatively

    Inflammatory response and stress response as quantified by IL-10 serum levels. Blood sample collection will take place in both study groups.

    Time frame: 1) Preoperatively (as a baseline)

  10. Surgical Stress Response - IL-10 - 15 minutes after aortic cross-clamp

    Inflammatory response and stress response as quantified by IL-10 serum levels. Blood sample collection will take place in both study groups.

    Time frame: 2) 15 minutes after aortic cross-clamping

  11. Surgical Stress Response - IL-10 - 60 minutes after aortic cross-clamp

    Inflammatory response and stress response as quantified by IL-10 serum levels. Blood sample collection will take place in both study groups.

    Time frame: 3) 60 minutes after aortic cross-clamp release

  12. Surgical Stress Response - IL-10 - 24 hours after aortic cross-clamp release

    Inflammatory response and stress response as quantified by IL-10 serum levels. Blood sample collection will take place in both study groups.

    Time frame: 4) 24 hours after aortic cross-clamp release

  13. Surgical Stress Response - Copeptin - Preoperatively

    Inflammatory response and stress response as quantified by Copeptin serum levels. Blood sample collection will take place in both study groups.

    Time frame: 1) Preoperatively (as a baseline)

  14. Surgical Stress Response - Copeptin - 15 minutes after aortic cross-clamp

    Inflammatory response and stress response as quantified by Copeptin serum levels. Blood sample collection will take place in both study groups.

    Time frame: 2) 15 minutes after aortic cross-clamping

  15. Surgical Stress Response - Copeptin - 60 minutes after aortic cross-clamp

    Inflammatory response and stress response as quantified by Copeptin serum levels. Blood sample collection will take place in both study groups.

    Time frame: 3) 60 minutes after aortic cross-clamp release

  16. Surgical Stress Response - Copeptin - 24 hours after aortic cross-clamp release

    Inflammatory response and stress response as quantified by AVP serum levels. Blood sample collection will take place in both study groups.

    Time frame: 4) 24 hours after aortic cross-clamp release

  17. Surgical Stress Response - TNF-a - Preoperatively

    Inflammatory response and stress response as quantified by TNF-a serum levels. Blood sample collection will take place in both study groups.

    Time frame: 1) Preoperatively (as a baseline)

  18. Surgical Stress Response - TNF-a - 15 minutes after aortic cross-clamp

    Inflammatory response and stress response as quantified by TNF-a serum levels. Blood sample collection will take place in both study groups.

    Time frame: 2) 15 minutes after aortic cross-clamping

  19. Surgical Stress Response - TNF-a - 60 minutes after aortic cross-clamp

    Inflammatory response and stress response as quantified by TNF-a serum levels. Blood sample collection will take place in both study groups.

    Time frame: 3) 60 minutes after aortic cross-clamp release

  20. Surgical Stress Response - TNF-a - 24 hours after aortic cross-clamp release

    Inflammatory response and stress response as quantified by TNF-a serum levels. Blood sample collection will take place in both study groups.

    Time frame: 4) 24 hours after aortic cross-clamp release

  21. Surgical Stress Response - Cortisol - Preoperatively

    Inflammatory response and stress response as quantified by cortisol serum levels. Blood sample collection will take place in both study groups.

    Time frame: 1) Preoperatively (as a baseline)

  22. Surgical Stress Response - Cortisol - 15 minutes after aortic cross-clamp

    Inflammatory response and stress response as quantified by cortisol serum levels. Blood sample collection will take place in both study groups.

    Time frame: 2) 15 minutes after aortic cross-clamping

  23. Surgical Stress Response - Cortisol - 60 minutes after aortic cross-clamp

    Inflammatory response and stress response as quantified by cortisol serum levels. Blood sample collection will take place in both study groups.

    Time frame: 3) 60 minutes after aortic cross-clamp release

  24. Surgical Stress Response - Cortisol - 24 hours after aortic cross-clamp release

    Inflammatory response and stress response as quantified by cortisol serum levels. Blood sample collection will take place in both study groups.

    Time frame: 4) 24 hours after aortic cross-clamp release

  25. Surgical Stress Response - CRP - Preoperatively

    Inflammatory response and stress response as quantified by CRP serum levels. Blood sample collection will take place in both study groups.

    Time frame: 1) Preoperatively (as a baseline)

  26. Surgical Stress Response - CRP - 15 minutes after aortic cross-clamp

    Inflammatory response and stress response as quantified by CRP serum levels. Blood sample collection will take place in both study groups.

    Time frame: 2) 15 minutes after aortic cross-clamping

  27. Surgical Stress Response - CRP - 60 minutes after aortic cross-clamp

    Inflammatory response and stress response as quantified by CRP serum levels. Blood sample collection will take place in both study groups.

    Time frame: 3) 60 minutes after aortic cross-clamp release

  28. Surgical Stress Response - CRP - 24 hours after aortic cross-clamp release

    Inflammatory response and stress response as quantified by CRP serum levels. Blood sample collection will take place in both study groups.

    Time frame: 4) 24 hours after aortic cross-clamp release

  29. Surgical Stress Response - WBC - Preoperatively

    Inflammatory response and stress response as quantified by WBC count. Blood sample collection will take place in both study groups.

    Time frame: 1) Preoperatively (as a baseline)

  30. Surgical Stress Response - WBC - 15 minutes after aortic cross-clamp

    Inflammatory response and stress response as quantified by WBC count. Blood sample collection will take place in both study groups.

    Time frame: 2) 15 minutes after aortic cross-clamping

  31. Surgical Stress Response - WBC - 60 minutes after aortic cross-clamp

    Inflammatory response and stress response as quantified by WBC count. Blood sample collection will take place in both study groups.

    Time frame: 3) 60 minutes after aortic cross-clamp release

  32. Surgical Stress Response - WBC - 24 hours after aortic cross-clamp release

    Inflammatory response and stress response as quantified by WBC count. Blood sample collection will take place in both study groups.

    Time frame: 4) 24 hours after aortic cross-clamp release

  33. Haemodynamic Stability - Tachycardia

    Intraoperative Tachycardia (defined as PR≥ 100 bpm), with episodes lasting ≥1 minute. Data will be reported in as a percentage of the total surgical time in which the participant exhibited tachycardia.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  34. Haemodynamic Stability - Bradycardia

    Intraoperative Bradycardia (defined as PR≤ 40 bpm), with episodes lasting ≥1 minute. Data will be reported in as a percentage of the total surgical time in which the participant exhibited bradycardia.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  35. Haemodynamic Stability - Hypotension SBP

    Intraoperative Hypotension (defined as SBP≤90mmHg or ≤80% of preoperative Baseline), with episodes lasting ≥1 minute. All patients will have a 5 minute preoperative SBP baseline, with measurements every 20 seconds. Intraoperative data will be compared to the mean preoperative 5 minute SPB baseline. Data will be reported in as a percentage of the total surgical time in which the participant exhibited hypotension, based on the SBP values.

    Time frame: Baseline: 5 minutes prior to anaesthesia induction. Intraoperative Hypotension: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  36. Haemodynamic Stability - Hypotension MBP

    Intraoperative Hypotension (defined as MBP≤65mmHg or ≤80% of preoperative Baseline), with episodes lasting ≥1 minute. All patients will have a 5 minute preoperative MBP baseline, with measurements every 20 seconds. Intraoperative data will be compared to the mean preoperative 5 minute MPB baseline. Data will be reported in as a percentage of the total surgical time in which the participant exhibited hypotension, based on the MBP values.

    Time frame: Baseline: 5 minutes prior to anaesthesia induction. Intraoperative Hypotension: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  37. Haemodynamic Stability - Hypertension

    Intraoperative Hypertension (defined as SBP ≥120% of preoperative Baseline), with episodes lasting ≥1 minute. All patients will have a 5 minute preoperative SBP baseline, with measurements every 20 seconds. Intraoperative data will be compared to the mean preoperative 5 minute SPB baseline. Data will be reported in as a percentage of the total surgical time in which the participant exhibited hypertension, based on the SBP values.

    Time frame: Baseline: 5 minutes prior to anaesthesia induction. Intraoperative Hypotension: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  38. Haemodynamic Stability - Fluid requirements - Crystalloids - Intraoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Crystaloid Fluid Requirements averaged over the total surgical time. Data will be reported in ml/kg\*h.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  39. Haemodynamic Stability - Fluid requirements - Crystalloids - 24 hours postoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Crystaloid Fluid Requirements. Data will be reported in ml/kg\*h.

    Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

  40. Haemodynamic Stability - Fluid requirements - Colloids - Intraoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Colloid Fluid Requirements averaged over the total surgical time. Data will be reported in ml/kg\*h.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  41. Haemodynamic Stability - Fluid requirements - Colloids - 24 hours postoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Colloid Fluid Requirements. Data will be reported in ml/kg\*h.

    Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

  42. Haemodynamic Stability - Fluid requirements - Concentrated RBCs - Intraoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Concentrated RBC unit Requirements. Data will be reported in ml.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  43. Haemodynamic Stability - Fluid requirements - Concentrated RBCs - 24 hours postoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Concentrated RBC unit Requirements. Data will be reported in ml.

    Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

  44. Haemodynamic Stability - Fluid requirements - Plasma - Intraoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Plasma unit Requirements. Data will be reported in ml.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  45. Haemodynamic Stability - Fluid requirements - Plasma - 24 hours postoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Plasma unit Requirements. Data will be reported in ml.

    Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

  46. Haemodynamic Stability - Fluid requirements - Platelets - Intraoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Platelet unit Requirements. Data will be reported in ml.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  47. Haemodynamic Stability - Fluid requirements - Platelets - 24 hours postoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Platelet unit Requirements. Data will be reported in ml.

    Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

  48. Haemodynamic Stability - Blood Loss - Intraoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Blood Loss. Data will be reported in ml.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  49. Haemodynamic Stability - Blood Loss - 24 hours postoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Blood Loss. Data will be reported in ml.

    Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

  50. Haemodynamic Stability - Fluid Balance - Intraoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Fluid Balance averaged over the total surgical time. Data will be reported in ml/kg/h

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  51. Haemodynamic Stability - Fluid Balance - 24 hours postoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Fluid Balance. Data will be reported in ml.

    Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

  52. Haemodynamic Stability - Vasoactive Requirements - Adrenaline - Intraoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Adrenaline requirements. Data will be reported in mg.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  53. Haemodynamic Stability - Vasoactive Requirements - Adrenaline - 24 hours postoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Adrenaline requirements. Data will be reported in mg.

    Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

  54. Haemodynamic Stability - Vasoactive Requirements - Noradrenaline - Intraoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Noradrenaline requirements. Data will be reported as an averaged intraoperative rate in mcg/kg\*min.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  55. Haemodynamic Stability - Vasoactive Requirements - Noradrenaline - 24 hours postoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Noradrenaline requirements. Data will be reported as an averaged rate in mcg/kg\*min.

    Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

  56. Haemodynamic Stability - Vasoactive Requirements - Ephedrine - Intraoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Ephedrine requirements. Data will be reported in mg.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  57. Haemodynamic Stability - Vasoactive Requirements - Ephedrine - 24 hours postoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Ephedrine requirements. Data will be reported in mg.

    Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

  58. Haemodynamic Stability - Vasoactive Requirements - Phenylephrine - Intraoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Phenylephrine requirements. Data will be reported as an averaged intraoperative rate in mcg/kg\*min.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  59. Haemodynamic Stability - Vasoactive Requirements - Phenylephrine - 24 hours postoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Phenylephrine requirements.Data will be reported as an averaged rate in mcg/kg\*min.

    Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

  60. Haemodynamic Stability - Vasoactive Requirements - Dobutamine - Intraoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Dobutamine requirements. Data will be reported as an averaged intraoperative rate in mcg/kg\*min.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  61. Haemodynamic Stability - Vasoactive Requirements - Dobutamine - 24 hours postoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Dobutamine requirements. Data will be reported as an averaged rate in mcg/kg\*min.

    Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

  62. Haemodynamic Stability - Vasoactive Requirements - Dopamine - Intraoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Dopamine requirements. Data will be reported as an averaged intraoperative rate in mcg/kg\*min.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  63. Haemodynamic Stability - Vasoactive Requirements - Dopamine - 24 hours postoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Dopamine requirements. Data will be reported as an averaged rate in mcg/kg\*min.

    Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

  64. Haemodynamic Stability - Vasoactive Requirements - Nitroglycerine - Intraoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Nitroglycerine requirements. Data will be reported as an averaged intraoperative rate in mcg/kg\*min.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  65. Haemodynamic Stability - Vasoactive Requirements - Nitroglycerine - 24 hours postoperatively

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Nitroglycerine requirements. Data will be reported as an averaged rate in mcg/kg\*min.

    Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

Secondary outcomes

  1. Postoperative pain - Numerical Rating Scale (NRS) - Immediately Postoperatively

    Evaluation of patients' pain using scales: Numerical Rating Scale (NRS). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").

    Time frame: 1) Immediately postoperatively (if awakened prior to ICU admission)

  2. Postoperative pain - Numerical Rating Scale (NRS) - First postoperative day

    Evaluation of patients' pain using scales: Numerical Rating Scale (NRS). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").

    Time frame: 2) First postoperative day

  3. Postoperative pain - Numerical Rating Scale (NRS) - Second postoperative day

    Evaluation of patients' pain using scales: Numerical Rating Scale (NRS). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").

    Time frame: 3) Second postoperative day

  4. Postoperative pain - Numerical Rating Scale (NRS) - Third postoperative day

    Evaluation of patients' pain using scales: Numerical Rating Scale (NRS). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").

    Time frame: 4) Third postoperative day

  5. Postoperative pain - Critical Care Pain Observation Tool (CPOT) - Immediately Postoperatively

    Evaluation of patients' pain using scales: Critical Care Pain Observation Tool (CPOT). The scale consists of four behavioral domains: facial expression, body movements, muscle tension and compliance with the ventilation for intubated patients or vocalization for extubated patients. Patient's behavior in each domain is scored between 0 and 2. The possible total score ranges from 0 (no pain) to 8 (maximum pain).

    Time frame: 1) Immediately postoperatively (if awakened prior to ICU admission)

  6. Postoperative pain - Critical Care Pain Observation Tool (CPOT) - First postoperative day

    Evaluation of patients' pain using scales: Critical Care Pain Observation Tool (CPOT). The scale consists of four behavioral domains: facial expression, body movements, muscle tension and compliance with the ventilation for intubated patients or vocalization for extubated patients. Patient's behavior in each domain is scored between 0 and 2. The possible total score ranges from 0 (no pain) to 8 (maximum pain).

    Time frame: 2) First postoperative day

  7. Postoperative pain - Critical Care Pain Observation Tool (CPOT) - Second postoperative day

    Evaluation of patients' pain using scales: Critical Care Pain Observation Tool (CPOT). The scale consists of four behavioral domains: facial expression, body movements, muscle tension and compliance with the ventilation for intubated patients or vocalization for extubated patients. Patient's behavior in each domain is scored between 0 and 2. The possible total score ranges from 0 (no pain) to 8 (maximum pain).

    Time frame: 3) Second postoperative day

  8. Postoperative pain - Critical Care Pain Observation Tool (CPOT) - Third postoperative day

    Evaluation of patients' pain using scales: Critical Care Pain Observation Tool (CPOT). The scale consists of four behavioral domains: facial expression, body movements, muscle tension and compliance with the ventilation for intubated patients or vocalization for extubated patients. Patient's behavior in each domain is scored between 0 and 2. The possible total score ranges from 0 (no pain) to 8 (maximum pain).

    Time frame: 4) Third postoperative day

  9. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Intolerable - First postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: 1. Intolerable 2. Tolerable with discomfort 3. Comfortably manageable 4. Negligible Pain The percentage of patients that report pain that is "Intolerable" will be reported

    Time frame: 1) First postoperative day

  10. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Intolerable - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: 1. Intolerable 2. Tolerable with discomfort 3. Comfortably manageable 4. Negligible Pain The percentage of patients that report pain that is "Intolerable" will be reported

    Time frame: 2) Second postoperative day

  11. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Intolerable - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: 1. Intolerable 2. Tolerable with discomfort 3. Comfortably manageable 4. Negligible Pain The percentage of patients that report pain that is "Intolerable" will be reported

    Time frame: 3) Third postoperative day

  12. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Tolerable with discomfort - First postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: 1. Intolerable 2. Tolerable with discomfort 3. Comfortably manageable 4. Negligible Pain The percentage of patients that report pain that is "Tolerable with discomfort" will be reported

    Time frame: 1) First postoperative day

  13. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Tolerable with discomfort - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: 1. Intolerable 2. Tolerable with discomfort 3. Comfortably manageable 4. Negligible Pain The percentage of patients that report pain that is "Tolerable with discomfort" will be reported

    Time frame: 2) Second postoperative day

  14. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Tolerable with discomfort - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: 1. Intolerable 2. Tolerable with discomfort 3. Comfortably manageable 4. Negligible Pain The percentage of patients that report pain that is "Tolerable with discomfort" will be reported

    Time frame: 3) Third postoperative day

  15. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Comfortably manageable - First postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: 1. Intolerable 2. Tolerable with discomfort 3. Comfortably manageable 4. Negligible Pain The percentage of patients that report pain that is "Comfortably manageable" will be reported

    Time frame: 1) First postoperative day

  16. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Comfortably manageable - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: 1. Intolerable 2. Tolerable with discomfort 3. Comfortably manageable 4. Negligible Pain The percentage of patients that report pain that is "Comfortably manageable" will be reported

    Time frame: 2) Second postoperative day

  17. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Comfortably manageable - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: 1. Intolerable 2. Tolerable with discomfort 3. Comfortably manageable 4. Negligible Pain The percentage of patients that report pain that is "Comfortably manageable" will be reported

    Time frame: 3) Third postoperative day

  18. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Negligible Pain - First postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: 1. Intolerable 2. Tolerable with discomfort 3. Comfortably manageable 4. Negligible Pain The percentage of patients that report pain that is "Negligible Pain" will be reported

    Time frame: 1) First postoperative day

  19. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Negligible Pain - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: 1. Intolerable 2. Tolerable with discomfort 3. Comfortably manageable 4. Negligible Pain The percentage of patients that report pain that is "Negligible Pain" will be reported

    Time frame: 2) Second postoperative day

  20. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Comfort - Negligible Pain - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to how comfortable patients feel with their pain, available answers will be: 1. Intolerable 2. Tolerable with discomfort 3. Comfortably manageable 4. Negligible Pain The percentage of patients that report pain that is "Negligible Pain" will be reported

    Time frame: 3) Third postoperative day

  21. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - Getting Worse - First postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: 1. Getting worse 2. About the same 3. Getting better The percentage of patients that report pain that is "Getting worse" will be reported

    Time frame: 1) First postoperative day

  22. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - Getting Worse - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: 1. Getting worse 2. About the same 3. Getting better The percentage of patients that report pain that is "Getting worse" will be reported

    Time frame: 2) Second postoperative day

  23. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - Getting Worse - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: 1. Getting worse 2. About the same 3. Getting better The percentage of patients that report pain that is "Getting worse" will be reported

    Time frame: 3) Third postoperative day

  24. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - About the same - First postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: 1. Getting worse 2. About the same 3. Getting better The percentage of patients that report pain that is "About the same" will be reported

    Time frame: 1) First postoperative day

  25. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - About the same - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: 1. Getting worse 2. About the same 3. Getting better The percentage of patients that report pain that is "About the same" will be reported

    Time frame: 2) Second postoperative day

  26. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - About the same - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: 1. Getting worse 2. About the same 3. Getting better The percentage of patients that report pain that is "About the same" will be reported

    Time frame: 3) Third postoperative day

  27. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - Getting better

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: 1. Getting worse 2. About the same 3. Getting better The percentage of patients that report pain that is "Getting better" will be reported

    Time frame: 1) First postoperative day

  28. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - Getting better - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: 1. Getting worse 2. About the same 3. Getting better The percentage of patients that report pain that is "Getting better" will be reported

    Time frame: 2) Second postoperative day

  29. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Change in Pain - Getting better - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to changes in pain perception by patients, available answers will be: 1. Getting worse 2. About the same 3. Getting better The percentage of patients that report pain that is "Getting better" will be reported

    Time frame: 3) Third postoperative day

  30. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Inadequate pain control - First postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: 1. Inadequate pain control 2. Effective, just about right 3. Would like to reduce medication The percentage of patients that report "Inadequate pain control" will be reported

    Time frame: 1) First postoperative day

  31. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Inadequate pain control - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: 1. Inadequate pain control 2. Effective, just about right 3. Would like to reduce medication The percentage of patients that report "Inadequate pain control" will be reported

    Time frame: 2) Second postoperative day

  32. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Inadequate pain control - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: 1. Inadequate pain control 2. Effective, just about right 3. Would like to reduce medication The percentage of patients that report "Inadequate pain control" will be reported

    Time frame: 3) Third postoperative day

  33. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Effective, just about right - First postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: 1. Inadequate pain control 2. Effective, just about right 3. Would like to reduce medication The percentage of patients that report pain control that is "Effective, just about right" will be reported

    Time frame: 1) First postoperative day

  34. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Effective, just about right - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: 1. Inadequate pain control 2. Effective, just about right 3. Would like to reduce medication The percentage of patients that report pain control that is "Effective, just about right" will be reported

    Time frame: 2) Second postoperative day

  35. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Effective, just about right - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: 1. Inadequate pain control 2. Effective, just about right 3. Would like to reduce medication The percentage of patients that report pain control that is "Effective, just about right" will be reported

    Time frame: 3) Third postoperative day

  36. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Would like to reduce medication - First postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: 1. Inadequate pain control 2. Effective, just about right 3. Would like to reduce medication The percentage of patients whose pain control is reported as "Would like to reduce medication" will be reported

    Time frame: 1) First postoperative day

  37. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Would like to reduce medication - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: 1. Inadequate pain control 2. Effective, just about right 3. Would like to reduce medication The percentage of patients whose pain control is reported as "Would like to reduce medication" will be reported

    Time frame: 2) Second postoperative day

  38. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Pain control - Would like to reduce medication - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to pain control reported by patients, available answers will be: 1. Inadequate pain control 2. Effective, just about right 3. Would like to reduce medication The percentage of patients whose pain control is reported as "Would like to reduce medication" will be reported

    Time frame: 3) Third postoperative day

  39. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can't do anything because of pain - First postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: 1. Can't do anything because of pain 2. Pain keeps me from doing most of what I need to do 3. Can do most things, but pain gets in the way of some 4. Can do everything I need to do The percentage of patients whose functioning is reported as "Can't do anything because of pain" will be reported

    Time frame: 1) First postoperative day

  40. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can't do anything because of pain - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: 1. Can't do anything because of pain 2. Pain keeps me from doing most of what I need to do 3. Can do most things, but pain gets in the way of some 4. Can do everything I need to do The percentage of patients whose functioning is reported as "Can't do anything because of pain" will be reported

    Time frame: 2) Second postoperative day

  41. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can't do anything because of pain - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: 1. Can't do anything because of pain 2. Pain keeps me from doing most of what I need to do 3. Can do most things, but pain gets in the way of some 4. Can do everything I need to do The percentage of patients whose functioning is reported as "Can't do anything because of pain" will be reported

    Time frame: 3) Third postoperative day

  42. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Pain keeps me from doing most of what I need to do - First postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: 1. Can't do anything because of pain 2. Pain keeps me from doing most of what I need to do 3. Can do most things, but pain gets in the way of some 4. Can do everything I need to do The percentage of patients whose functioning is reported as "Pain keeps me from doing most of what I need to do" will be reported

    Time frame: 1) First postoperative day

  43. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Pain keeps me from doing most of what I need to do - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: 1. Can't do anything because of pain 2. Pain keeps me from doing most of what I need to do 3. Can do most things, but pain gets in the way of some 4. Can do everything I need to do The percentage of patients whose functioning is reported as "Pain keeps me from doing most of what I need to do" will be reported

    Time frame: 2) Second postoperative day

  44. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Pain keeps me from doing most of what I need to do - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: 1. Can't do anything because of pain 2. Pain keeps me from doing most of what I need to do 3. Can do most things, but pain gets in the way of some 4. Can do everything I need to do The percentage of patients whose functioning is reported as "Pain keeps me from doing most of what I need to do" will be reported

    Time frame: 3) Third postoperative day

  45. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can do most things, but pain gets in the way of some - First postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: 1. Can't do anything because of pain 2. Pain keeps me from doing most of what I need to do 3. Can do most things, but pain gets in the way of some 4. Can do everything I need to do The percentage of patients whose functioning is reported as "Can do most things, but pain gets in the way of some" will be reported

    Time frame: 1) First postoperative day

  46. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can do most things, but pain gets in the way of some - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: 1. Can't do anything because of pain 2. Pain keeps me from doing most of what I need to do 3. Can do most things, but pain gets in the way of some 4. Can do everything I need to do The percentage of patients whose functioning is reported as "Can do most things, but pain gets in the way of some" will be reported

    Time frame: 2) Second postoperative day

  47. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can do most things, but pain gets in the way of some - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: 1. Can't do anything because of pain 2. Pain keeps me from doing most of what I need to do 3. Can do most things, but pain gets in the way of some 4. Can do everything I need to do The percentage of patients whose functioning is reported as "Can do most things, but pain gets in the way of some" will be reported

    Time frame: 3) Third postoperative day

  48. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can do everything I need to do - First postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: 1. Can't do anything because of pain 2. Pain keeps me from doing most of what I need to do 3. Can do most things, but pain gets in the way of some 4. Can do everything I need to do The percentage of patients whose functioning is reported as "Can do everything I need to do" will be reported

    Time frame: 1) First postoperative day

  49. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can do everything I need to do - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: 1. Can't do anything because of pain 2. Pain keeps me from doing most of what I need to do 3. Can do most things, but pain gets in the way of some 4. Can do everything I need to do The percentage of patients whose functioning is reported as "Can do everything I need to do" will be reported

    Time frame: 2) Second postoperative day

  50. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Functioning - Can do everything I need to do - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to functioning - for the usual things patients need to do, available answers will be: 1. Can't do anything because of pain 2. Pain keeps me from doing most of what I need to do 3. Can do most things, but pain gets in the way of some 4. Can do everything I need to do The percentage of patients whose functioning is reported as "Can do everything I need to do" will be reported

    Time frame: 3) Third postoperative day

  51. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Awake with pain most of the night - First postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: 1. Awake with pain most of the night 2. Awake with occasional pain 3. Normal sleep The percentage of patients whose sleep is reported as "Awake with pain most of the night" will be reported

    Time frame: 1) First postoperative day

  52. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Awake with pain most of the night - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: 1. Awake with pain most of the night 2. Awake with occasional pain 3. Normal sleep The percentage of patients whose sleep is reported as "Awake with pain most of the night" will be reported

    Time frame: 2) Second postoperative day

  53. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Awake with pain most of the night - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: 1. Awake with pain most of the night 2. Awake with occasional pain 3. Normal sleep The percentage of patients whose sleep is reported as "Awake with pain most of the night" will be reported

    Time frame: 3) Third postoperative day

  54. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Awake with occasional pain - First postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: 1. Awake with pain most of the night 2. Awake with occasional pain 3. Normal sleep The percentage of patients whose sleep is reported as "Awake with occasional pain" will be reported

    Time frame: 1) First postoperative day

  55. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Awake with occasional pain - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: 1. Awake with pain most of the night 2. Awake with occasional pain 3. Normal sleep The percentage of patients whose sleep is reported as "Awake with occasional pain" will be reported

    Time frame: 2) Second postoperative day

  56. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Awake with occasional pain - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: 1. Awake with pain most of the night 2. Awake with occasional pain 3. Normal sleep The percentage of patients whose sleep is reported as "Awake with occasional pain" will be reported

    Time frame: 3) Third postoperative day

  57. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Normal sleep - First postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: 1. Awake with pain most of the night 2. Awake with occasional pain 3. Normal sleep The percentage of patients whose sleep is reported as "Normal sleep" will be reported

    Time frame: 1) First postoperative day

  58. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Normal sleep - Second postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: 1. Awake with pain most of the night 2. Awake with occasional pain 3. Normal sleep The percentage of patients whose sleep is reported as "Normal sleep" will be reported

    Time frame: 2) Second postoperative day

  59. Postoperative pain - Clinically Aligned Pain Assessment Tool (CAPA) - Sleep - Normal sleep - Third postoperative day

    Evaluation of patients' pain using scales: Clinically Aligned Pain Assessment Tool (CAPA). Patients will be given a standardized CAPA questionaire that has pre-determined answers that patients will be able to choose from, to best describe their pain. In regards to sleep, if the pain is waking patients up, available answers will be: 1. Awake with pain most of the night 2. Awake with occasional pain 3. Normal sleep The percentage of patients whose sleep is reported as "Normal sleep" will be reported

    Time frame: 3) Third postoperative day

  60. Analgesic Requirements - First postoperative day

    Evaluation of patients' pain by recording the number of times that rescue analgesia (tramadol) was required.

    Time frame: 1) First postoperative day

  61. Analgesic Requirements - Second postoperative day

    Evaluation of patients' pain by recording the number of times that rescue analgesia (tramadol) was required.

    Time frame: 2) Second postoperative day

  62. Analgesic Requirements - Third postoperative day

    Evaluation of patients' pain by recording the number of times that rescue analgesia (tramadol) was required.

    Time frame: 3) Third postoperative day

  63. Kidney function - Furosemide requirement - Intraoperatively

    Kidney function as quantified by furosemide requirement to maintain urine output. Data will be reported in mg.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  64. Kidney function - Furosemide requirement - 24 hours postoperatively

    Kidney function as quantified by furosemide requirement to maintain urine output. Data will be reported in mg.

    Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

  65. Kidney function - MDRD GFR - Preoperatively

    Kidney function as assessed by preoperative GFR calculated by the MDRD GFR equation.

    Time frame: 1) Preoperatively (as a baseline)

  66. Kidney function - MDRD GFR - Immediately postoperatively

    Kidney function as assessed by postoperative GFR calculated by the MDRD GFR equation.

    Time frame: 2) At the end of surgery 1h after the end of placement of last suture/surgical clip on patient, upon ICU admission.

  67. Kidney function - MDRD GFR - 24h Postoperatively

    Kidney function as assessed by postoperative GFR calculated by the MDRD GFR equation.

    Time frame: 3) 24h postoperatively

  68. Kidney function - Urine Output - Intraoperatively

    Kidney function as quantified by urine output. Data will be reported as an averaged intraoperative rate in ml/kg\*h.

    Time frame: From anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours

  69. Kidney function - Urine Output - 24 hours postoperatively

    Kidney function as quantified by urine output. Data will be reported as an averaged rate in ml/kg\*h.

    Time frame: From the end of surgery (end of placement of last suture/surgical clip on patient) until 24 hours postoperatively

  70. Length of stay - ICU

    All patients will spend at least 1 day in the ICU for postoperative monitoring. ICU length of stay will be reported in days.

    Time frame: From day of surgery until day of ICU stay.

  71. Length of stay - Hospital Discharge

    Hospital length of stay will be reported in days.

    Time frame: From day of surgery until hospital discharge

Other outcomes

  1. Haemodynamic Stability - Coefficient of Variation PR

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Pulse Rate - PR. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Coefficient of variation of the PR values will be reported for each patient, extracted from the collected data.

    Time frame: Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.

  2. Haemodynamic Stability - Average Real Variability PR

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Average Real Variability of the PR. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Values will be averaged every minute and the Average Real Variability will be reported for each patient, extracted from the collected data.

    Time frame: Every minute from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.

  3. Haemodynamic Stability - Coefficient of Variation SBP

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Systolic Blood Pressure - SBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Coefficient of variation of SBP values will be reported for each patient, extracted from the collected data.

    Time frame: Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.

  4. Haemodynamic Stability - Average Real Variability SBP

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Average Real Variability of the SBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Values will be averaged every minute and the Average Real Variability will be reported for each patient, extracted from the collected data.

    Time frame: Every minute from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.

  5. Haemodynamic Stability - Coefficient of Variation DBP

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Diastolic Blood Pressure - DBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Coefficient of variation of DBP values will be reported for each patient, extracted from the collected data.

    Time frame: Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.

  6. Haemodynamic Stability - Average Real Variability DBP

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Average Real Variability of the DBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Values will be averaged every minute and the Average Real Variability will be reported for each patient, extracted from the collected data.

    Time frame: Every minute from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.

  7. Haemodynamic Stability - Coefficient of Variation MBP

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Mean Blood Pressure - MBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Coefficient of variation of MBP values will be reported for each patient, extracted from the collected data.

    Time frame: Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.

  8. Haemodynamic Stability - Average Real Variability MBP

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Average Real Variability of the MBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Values will be averaged every minute and the Average Real Variability will be reported for each patient, extracted from the collected data.

    Time frame: Every minute from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.

  9. Haemodynamic Stability - Coefficient of Variation PP

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Pulse Pressure. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Coefficient of variation of PP values will be reported for each patient, extracted from the collected data.

    Time frame: Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.

  10. Haemodynamic Stability - Average Real Variability PP

    Haemodynamic Stability as quantified by hemodynamic markers, specifically Average Real Variability of the PP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Values will be averaged every minute and the Average Real Variability will be reported for each patient, extracted from the collected data.

    Time frame: Every minute from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Norman PE, Semmens JB, Lawrence-Brown MM. Long-term relative survival following surgery for abdominal aortic aneurysm: a review. Cardiovasc Surg. 2001 Jun;9(3):219-24. doi: 10.1177/096721090100900303. PubMed 11336844 ↗
  • Johal AS, Loftus IM, Boyle JR, Heikkila K, Waton S, Cromwell DA. Long-term survival after endovascular and open repair of unruptured abdominal aortic aneurysm. Br J Surg. 2019 Dec;106(13):1784-1793. doi: 10.1002/bjs.11215. PubMed 31747067 ↗
  • Moris DN, Kontos MI, Mantonakis EI, Athanasiou AK, Spartalis ED, Bakoyiannis CN, Chrousos GP, Georgopoulos SE. Concept of the aortic aneurysm repair-related surgical stress: a review of the literature. Int J Clin Exp Med. 2014 Sep 15;7(9):2402-12. eCollection 2014. PubMed 25356092 ↗
  • Tsilimigras DI, Sigala F, Karaolanis G, Ntanasis-Stathopoulos I, Spartalis E, Spartalis M, Patelis N, Papalampros A, Long C, Moris D. Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review. Acta Pharmacol Sin. 2018 Jul;39(7):1164-1175. doi: 10.1038/aps.2017.212. Epub 2018 May 17. PubMed 29770795 ↗
  • Pearson S, Hassen T, Spark JI, Cabot J, Cowled P, Fitridge R. Endovascular repair of abdominal aortic aneurysm reduces intraoperative cortisol and perioperative morbidity. J Vasc Surg. 2005 Jun;41(6):919-25. doi: 10.1016/j.jvs.2005.02.040. PubMed 15944585 ↗
  • Wilt TJ, Lederle FA, Macdonald R, Jonk YC, Rector TS, Kane RL. Comparison of endovascular and open surgical repairs for abdominal aortic aneurysm. Evid Rep Technol Assess (Full Rep). 2006 Aug;(144):1-113. PubMed 17764213 ↗
  • Moore WS, Kashyap VS, Vescera CL, Quinones-Baldrich WJ. Abdominal aortic aneurysm: a 6-year comparison of endovascular versus transabdominal repair. Ann Surg. 1999 Sep;230(3):298-306; discussion 306-8. doi: 10.1097/00000658-199909000-00003. PubMed 10493477 ↗
  • Salartash K, Sternbergh WC 3rd, York JW, Money SR. Comparison of open transabdominal AAA repair with endovascular AAA repair in reduction of postoperative stress response. Ann Vasc Surg. 2001 Jan;15(1):53-9. doi: 10.1007/s100160010014. PubMed 11221945 ↗
  • Panaretou V, Siafaka I, Theodorou D, Manouras A, Seretis C, Gourgiotis S, Katsaragakis S, Sigala F, Zografos G, Filis K. Combined general-epidural anesthesia with continuous postoperative epidural analgesia preserves sigmoid colon perfusion in elective infrarenal aortic aneurysm repair. Saudi J Anaesth. 2012 Oct-Dec;6(4):373-9. doi: 10.4103/1658-354X.105870. PubMed 23493852 ↗
  • Jessula S, Atkinson L, Casey P, Kwofie K, Stewart S, Lee MS, Smith M, Herman CR. Surgically positioned paravertebral catheters and postoperative analgesia after open abdominal aortic aneurysm repair. J Vasc Surg. 2019 Nov;70(5):1479-1487. doi: 10.1016/j.jvs.2019.02.037. Epub 2019 May 29. PubMed 31153699 ↗
  • Panaretou V, Toufektzian L, Siafaka I, Kouroukli I, Sigala F, Vlachopoulos C, Katsaragakis S, Zografos G, Filis K. Postoperative pulmonary function after open abdominal aortic aneurysm repair in patients with chronic obstructive pulmonary disease: epidural versus intravenous analgesia. Ann Vasc Surg. 2012 Feb;26(2):149-55. doi: 10.1016/j.avsg.2011.04.009. Epub 2011 Oct 22. PubMed 22018500 ↗
  • Greco KJ, Brovman EY, Nguyen LL, Urman RD. The Impact of Epidural Analgesia on Perioperative Morbidity or Mortality after Open Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2020 Jul;66:44-53. doi: 10.1016/j.avsg.2019.10.054. Epub 2019 Oct 28. PubMed 31672606 ↗
  • Ammar AS, Mahmoud KM. Comparative effect of propofol versus sevoflurane on renal ischemia/reperfusion injury after elective open abdominal aortic aneurysm repair. Saudi J Anaesth. 2016 Jul-Sep;10(3):301-7. doi: 10.4103/1658-354X.174907. PubMed 27375385 ↗
  • Loggi S, Mininno N, Damiani E, Marini B, Adrario E, Scorcella C, Domizi R, Carsetti A, Pantanetti S, Pagliariccio G, Carbonari L, Donati A. Changes in the sublingual microcirculation following aortic surgery under balanced or total intravenous anaesthesia: a prospective observational study. BMC Anesthesiol. 2019 Jan 5;19(1):1. doi: 10.1186/s12871-018-0673-7. PubMed 30611197 ↗
  • Giudice V, Lauwick S, Kaba A, Joris J. [Proven and expected benefits of intravenous lidocaine administered during the perioperative period]. Rev Med Liege. 2012 Feb;67(2):81-4. French. PubMed 22482237 ↗
  • Liu FL, Chen TL, Chen RM. Mechanisms of ketamine-induced immunosuppression. Acta Anaesthesiol Taiwan. 2012 Dec;50(4):172-7. doi: 10.1016/j.aat.2012.12.001. Epub 2013 Jan 11. PubMed 23385040 ↗
  • Mojtahedzadeh M, Chelkeba L, Ranjvar-Shahrivar M, Najafi A, Moini M, Najmeddin F, Sadeghi K, Barkhordari K, Gheymati A, Ahmadi A. Randomized Trial of the Effect of Magnesium Sulfate Continuous Infusion on IL-6 and CRP Serum Levels Following Abdominal Aortic Aneurysm Surgery. Iran J Pharm Res. 2016 Fall;15(4):951-956. PubMed 28243294 ↗
  • Marik PE. Propofol: an immunomodulating agent. Pharmacotherapy. 2005 May;25(5 Pt 2):28S-33S. doi: 10.1592/phco.2005.25.5_part_2.28s. PubMed 15899746 ↗
  • Roeckel LA, Utard V, Reiss D, Mouheiche J, Maurin H, Robe A, Audouard E, Wood JN, Goumon Y, Simonin F, Gaveriaux-Ruff C. Morphine-induced hyperalgesia involves mu opioid receptors and the metabolite morphine-3-glucuronide. Sci Rep. 2017 Sep 4;7(1):10406. doi: 10.1038/s41598-017-11120-4. PubMed 28871199 ↗
  • Yi P, Pryzbylkowski P. Opioid Induced Hyperalgesia. Pain Med. 2015 Oct;16 Suppl 1:S32-6. doi: 10.1111/pme.12914. PubMed 26461074 ↗
  • Mauermann E, Filitz J, Dolder P, Rentsch KM, Bandschapp O, Ruppen W. Does Fentanyl Lead to Opioid-induced Hyperalgesia in Healthy Volunteers?: A Double-blind, Randomized, Crossover Trial. Anesthesiology. 2016 Feb;124(2):453-63. doi: 10.1097/ALN.0000000000000976. PubMed 26655493 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04894864
Lead sponsor
University of Crete
Collaborators
University Hospital of Crete
Responsible party
George Papastratigakis, MD (Principal Investigator, University of Crete) — Principal investigator
First posted
May 20, 2021
Start date
Oct 8, 2020
Primary completion
Sep 1, 2026 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Jun 16, 2026

Study contacts

George Papastratigakis, MD
Contact
papastratigakisg@gmail.com
00306979056672
Georgios Stefanakis, MD
Contact
G_Stefanakis@yahoo.com
00306978779726
Vasileia Nyktari, MD,PhD
study chair · University of Crete, Medical School

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion